help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on June 5, 2003
Endocrinology, doi:10.1210/en.2003-0244
A more recent version of this article appeared on September 1, 2003
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
144/9/3895    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hewitt, K. N.
Right arrow Articles by Simpson, E. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hewitt, K. N.
Right arrow Articles by Simpson, E. R.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CHOLESTEROL
Medline Plus Health Information
*Dietary Fats

Submitted on February 24, 2003
Accepted on May 27, 2003

The aromatase knockout (ArKO) mouse presents with a sexually dimorphic disruption to cholesterol homeostasis

Kylie N. Hewitt1*, Wah Chin Boon1, Yoko Murata1, Margaret E.E. Jones1, and Evan R. Simpson1

1 Prince Henry's Institute of Medical Research, P.O. Box 5152, Clayton, Vic 3168, Australia. Department of Biochemistry and Molecular Biology, Monash University, Clayton, Vic, 3800, Australia.

* To whom correspondence should be addressed. E-mail: Kylie.Hewitt{at}med.monash.edu.au.

The ArKO mouse cannot synthesize endogenous estrogens due to disruption of the Cyp19 gene. We have shown previously, that ArKO mice present with age progressive obesity and hepatic steatosis, and by one year of age both male and female ArKO mice develop hypercholesterolemia. In this present study, 10-12 week old ArKO mice were challenged for 90 days with high cholesterol diets. Our results show a sexually dimorphic response to estrogen deficiency in terms of cholesterol homeostasis in the liver. ArKO females presented with elevated serum cholesterol; conversely ArKO males had elevated hepatic cholesterol levels. In response to dietary cholesterol, HMG CoA reductase transcript levels were significantly reduced in females, whereas males showed more modest changes. Neither LDLR nor SREBP2 expression levels were significantly altered by diet or genotype. Expression of Cyp7a, which encodes cholesterol 7{alpha}-hydroxylase, was significantly reduced in ArKO females compared with WT females, and was increased by cholesterol feeding. Cyp7a expression was significantly elevated in the WT males on high cholesterol diet although no difference was seen between genotypes on control diet. The ABCG5 and ABCG8 transporters do not appear to be regulated by estrogen. Expression of ACAT2 showed a sexually dimorphic response, where estrogen appeared to have a stimulatory effect in females but not males. This study reveals a sexual dimorphic difference in mouse hepatic cholesterol homeostasis and roles for estrogen in the regulation of cholesterol uptake, biosynthesis and catabolism in the female, but not the male.


Key words: estrogen • aromatase • cholesterol







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society